Our Products
At ADS, we specialize in providing cutting-edge pharmaceutical solutions to the Syrian market. With a deep-rooted commitment to patient health, we focus on a range of therapeutic areas, including:
Anti-TNF Therapies: We are a leading supplier of state-of-the-art Anti-TNF drugs, which are essential for treating various autoimmune diseases affecting the joints, digestive system, and skin.
Multiple Sclerosis Treatments: With over a decade of experience, we are at the forefront of providing innovative therapies for multiple sclerosis. We consistently introduce the latest global advancements to the Syrian market, contributing to improved outcomes for patients.
We are dedicated to delivering advanced cancer treatments, including:
Breast Cancer Medications: We offer both HER-2 positive and negative breast cancer therapies, ensuring access to the most effective treatments.
Malignancy Immunotherapy: We provide cutting-edge anti-PD-1 therapies, a revolutionary approach to treating a wide range of cancers.
Growth Hormone: We supply essential growth hormone treatments for children with growth disorders.
Osteoporosis Therapies: We offer a range of advanced therapies to combat osteoporosis and improve bone health.
Diabetes and Obesity Treatments: We provide modern medications for diabetes and obesity management.
We collaborate with global partners to supply the Syrian market with crucial blood derivative medications, clotting factors, and vaccines.
By providing these essential medications, we strive to improve the lives of patients in Syria. Our commitment to quality, innovation, and patient care drives us to continuously seek out the latest advancements in pharmaceutical science.
Anti-TNF Therapies: We are a leading supplier of state-of-the-art Anti-TNF drugs, which are essential for treating various autoimmune diseases affecting the joints, digestive system, and skin.
Multiple Sclerosis Treatments: With over a decade of experience, we are at the forefront of providing innovative therapies for multiple sclerosis. We consistently introduce the latest global advancements to the Syrian market, contributing to improved outcomes for patients.
We are dedicated to delivering advanced cancer treatments, including:
Breast Cancer Medications: We offer both HER-2 positive and negative breast cancer therapies, ensuring access to the most effective treatments.
Malignancy Immunotherapy: We provide cutting-edge anti-PD-1 therapies, a revolutionary approach to treating a wide range of cancers.
Growth Hormone: We supply essential growth hormone treatments for children with growth disorders.
Osteoporosis Therapies: We offer a range of advanced therapies to combat osteoporosis and improve bone health.
Diabetes and Obesity Treatments: We provide modern medications for diabetes and obesity management.
We collaborate with global partners to supply the Syrian market with crucial blood derivative medications, clotting factors, and vaccines.
By providing these essential medications, we strive to improve the lives of patients in Syria. Our commitment to quality, innovation, and patient care drives us to continuously seek out the latest advancements in pharmaceutical science.